139
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Assessment of Ventricular Repolarization in Sickle Cell Anemia Patients: The Role of QTc Interval, Tp-e Interval and Tp-e/QTc Ratio and Its Gender Implication

ORCID Icon, , , ORCID Icon, ORCID Icon, , ORCID Icon, & show all
Pages 525-533 | Published online: 07 Dec 2020

References

  • Potoka KP, Gladwin MT. Vasculopathy and pulmonary hypertension in sickle cell disease. Am J Physiol Lung Cell Mol Physiol. 2015;308(4):L314–L324. doi:10.1152/ajplung.00252.2014
  • Piccin A, Murphy C, Eakins E, et al. Insight into the complex pathophysiology of sickle cell anaemia and possible treatment. Eur J Haematol. 2019;102(4):319–330. doi:10.1111/ejh.13212
  • Gladwin TM, Sachdev V. Cardiovascular abnormalities in sickle cell disease. J Am Coll Cardiol. 2012;59:13.
  • Pearson HA. Reply: sickle cell disease in the Kingdom of Saudi Arabia: East and West. Ann Saudi Med. 1999;19:281–282.
  • Oduor H, Minniti CP, Brofferio A, et al. Severe cardiac iron toxicity in two adults with sickle cell disease. Transfusion. 2017;57(3):700–704.
  • Bode-Thomas F, Ogunkunle OO, Omotoso AB. Electrocardiographic and self-paced walking exercise features of Nigerians with sickle cell anaemia at OAUTHC, Ile-Ife. Nig J Med. 2002;11:170–176.
  • Kors JA, van Eck HJ, van Herpen G. The meaning of the Tp-Te interval and its diagnostic value. J Electrocardiol. 2008;41:575–580.
  • Gupta P, Patel C, Patel H, et al. T(p-e)/QT ratio as an index of arrhythmogenesis. J Electrocardiol. 2008;41:567–574.
  • Morita H, Wu J, Zipes DP. The QT syndromes: long and short. Lancet. 2008;372:750–763.
  • Montanez A, Ruskin JN, Hebert PR, et al. Prolonged QTc interval and risks of total and cardiovascular mortality and sudden death in the general population: a review and qualitative overview of the prospective cohort studies. Arch Intern Med. 2004;164(9):943–948. doi:10.1001/archinte.164.9.943
  • Zabel M, Klingenheben T, Franz MR, et al. Assessment of QT dispersion for prediction of mortality or arrhythmic events after myocardial infarction: results of a prospective, long-term follow-up study. Circulation. 1998;97(25):2543–2550. doi:10.1161/01.CIR.97.25.2543
  • Sahu P, Lim PO, Rana BS, et al. QT dispersion in medicine: electrophysiological holy grail or fool’s gold? QJM. 2000;93:425–431. doi:10.1093/qjmed/93.7.425
  • Piccin A, Sartori MT, Bisogno G, et al. New insights into sinusoidal obstruction syndrome. Intern Med J. 2017;47(10):1173–1183. doi:10.1111/imj.13550
  • Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502. doi:10.1093/clinchem/18.6.499
  • Famodu AA, Halim NKD, Odoemene DI, et al. Haemorheological changes in sickle cell disease: measurement and significance. Br J Biomed Sci. 1998;55:275.
  • Gordon RJ. Viscosity considerations in the determination of regional circulatory adjustments to anemia. Circ Res. 1972;31:805–812.
  • Oguanobi NI, Onwubere BJ, Ike SO, et al. Electrocardiographic findings in adult Nigerians with sickle cell anaemia. Afr Health Sci. 2010;10:235–241.
  • Liem RI, Young LT, Thompson AA. Prolonged QTc interval in children and young adults with sickle cell disease at steady state. Pediatr Blood Cancer. 2009;52(7):842–846. doi:10.1002/pbc.21973
  • Barr CS, Naas A, Freeman M, et al. QT dispersion and sudden unexpected death in chronic heart failure. Lancet. 1994;343(8893):327–329. doi:10.1016/S0140-6736(94)91164-9
  • Akgul F, Seyfeli E, Melek İ, et al. Increased QT dispersion in sickle cell disease: effect of pulmonary hypertension. Acta Haematol. 2007;118(1):1–6. doi:10.1159/000100929
  • Boga C, Kozanoglu I, Yeral M, et al. Assessment of corrected QT interval in sickle cell disease patients who undergo erythroapheresis. Transfus Med. 2007;17(6):466–472. doi:10.1111/j.1365-3148.2007.00801.x
  • Kilicaslan F, Tokatli A, Ozdag F, et al. Tp-e interval, Tp-e/QT ratio, and Tp-e/QTc ratio are prolonged in patients with moderate and severe obstructive sleep apnea. Pacing Clin Electrophysiol. 2012;35(8):966–972. doi:10.1111/j.1540-8159.2012.03439.x
  • Haarmark C, Hansen PR, Vedel-Larsen E, et al. The prognostic value of the tpeak-tend interval in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. J Electrocardiol. 2009;42:555–560.
  • Tasolar H, Ballı M, Cetin M, et al. Effects of the coronary collateral circulation on the Tp-e interval and Tp-e/QT ratio in patients with stable coronary artery disease. Ann Noninvasive Electrocardiol. 2015;20:53–61.
  • Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death [see comments]. N Engl J Med. 1994;330:1639–1644.
  • Wierenga KJJ, Hambleton IR, Lewis NA. Survival estimates for patients with homozygous sickle-cell disease in Jamaica: a clinic-based population study. Lancet. 2001;357(9257):680–683.
  • Sourander L, Rajala T, Räihä I, et al. Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT). Lancet. 1998;352:1965–1969.
  • Kim YD, Chen B, Beauregard J, et al. 17 beta-estradiol prevents dysfunction of canine coronary endothelium and myocardium and reperfusion arrhythmias after brief ischemia/reperfusion. Circulation. 1996;94:2901–2908.
  • Wang Y, Wang Q, Zhao Y, et al. Protective effects of estrogen against reperfusion arrhythmias following severe myocardial ischemia in rats. Circulation. 2010;74:634–643.
  • Nsiri B, Gritli N, Mazigh C, et al. Fibrinolytic response to venous occlusion in patients with homozygous sickle cell disease. Hematol Cell Ther. 1997;39:229–232.
  • Acar G, Yorgun H, Inci MF, et al. Evaluation of Tp-e interval and Tp-e/QT ratio in patients with ankylosing spondylitis. Mod Rheumatol. 2013.
  • Devaraj S, Xu DY, Jialal I. C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. Circulation. 2003;107:398–404.
  • Janse van Rensburg DC, Ker JA, Grant CC, et al. Autonomic impairment in rheumatoid arthritis. Int J Rheum Dis. 2012;15:419–426.
  • Mountantonakis S, Deo R. Biomarkers in atrial fibrillation, ventricular arrhythmias, and sudden cardiac death. Cardiovasc Ther. 2012;30:74–80.
  • Arslan E, Yiginer O, Yavasoglu I, et al. Effect of uncomplicated obesity on QT interval in young men. Pol Arch Med Wewn. 2010;120:209–213.